Clinical challenges and proposed solutions for patients with invasive lobular breast cancer [0.03%]
侵袭性小叶乳腺癌患者的临床难题及解决方案
K Van Baelen,E Sawyer,J Van Cauwenberge et al.
K Van Baelen et al.
Background: Invasive lobular carcinoma (ILC) is the second most common type of breast cancer and is increasingly recognized as a separate entity from invasive breast cancer of no-special type. Here, we present the current...
Tumour-infiltrating lymphocytes in refractory melanoma - not as hard as we thought? [0.03%]
顽固性黑色素瘤中的肿瘤浸润淋巴细胞并不像我们想象的那么困难？
A Javaid,S P Patel,J Larkin
A Javaid
THE OPERA TRIAL: THE ACTIVE ROLE OF THE PATIENT IN THE CLINICAL DECISION-MAKING PROCESS AND SURGICAL PLANNING [0.03%]
主动参与临床决策和手术规划的“病人歌剧”诉讼案
A Larcher,F Cei,A Mottrie et al.
A Larcher et al.
From epigenetic alterations to clinical impact: The role of DNMT3A in modulating immunotherapy response [0.03%]
从表观遗传改变到临床影响：DNA甲基转移酶DNMT3A在调节免疫治疗反应中的作用
M Khalil,M S Tsao
M Khalil
Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase 3 trials of docetaxel and zoledronic acid using healthcare systems data [0.03%]
基于医疗体系数据的STAMPEDE III期临床试验（多西他赛和唑来膦酸）中高危局限期或转移性激素敏感型前列腺癌新诊断患者的骨折相关住院情况：二次分析
C Jones,P Dutey-Magni,L R Murphy et al.
C Jones et al.
Background: Androgen deprivation therapy (ADT), the mainstay systemic treatment for high risk non-metastatic (M0) and metastatic (M1) prostate cancer (PCa) is associated with bone loss and increased fracture risk. The STA...
Final overall survival and safety analyses of the phase 3 PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer [0.03%]
PSMAfore III期临床试验最终总生存率和安全性分析：[177Lu]Lu-PSMA-617与初始使用雄激素受体通路抑制剂治疗未经紫杉烷类药物治疗的转移性去势抵抗性前列腺癌患者的对比研究
K Fizazi,K N Chi,N D Shore et al.
K Fizazi et al.
Background: In PSMAfore, [177Lu]Lu-PSMA-617 (177Lu-PSMA-617) prolonged radiographic progression-free survival (rPFS) in taxane-naive patients with metastatic castration-resistant prostate cancer (mCRPC), with a favourable...
Re-examining Post-operative Chemoradiotherapy in Head and Neck Cancer: An Updated Long-Term Combined Analysis of RTOG 9501/EORTC 22931 [0.03%]
头颈癌术后放化疗的再评估：RTOG 9501/EORTC 22931联合分析的长期更新数据
Z S Zumsteg,M Luu,C Fortpied et al.
Z S Zumsteg et al.
Background: Post-operative chemoradiation (CRT) is generally recommended for patients with extranodal extension (ENE) and/or positive margins, but not for patients without these features, based on a post-hoc analysis of R...
I A van Assche,E Huis In &#x;t Veld,K van Calsteren et al.
I A van Assche et al.
Editorial to: "Long-term development of 12- and 15-year-old offspring after maternal cancer diagnosis during pregnancy: a prospective multicentre cohort study" by E. A. Huis in 't Veld et al. Cancer During Pregnancy - a childbearing potential [0.03%]
论著《孕期罹患癌症的产妇所生12岁和15岁后代的长期发展——一项前瞻性多中心队列研究》（作者：艾哈·因特霍伊斯因特韦尔德等）- 孕期癌症-生育力受损
S Loibl,B Winter,M Reinisch
S Loibl